The COVID-19 pandemic provides an opportunity to reflect upon the crucial role of intellectual property (IP) in the on-going health crisis and dedicate IP to finding a permanent solution.

Vaccines – permanent solutions:

Do patents create roadblocks, or provide a solution?

Patent Exclusivity:

Patents grant exclusivity in the market to the owners for a limited period.

This exclusivity for drugs will last for as long as the primary patent is in place, usually 20 years.

The primary patent applies to the therapeutic active pharmaceutical ingredient (API).

Way forward:


Patent exclusivity accepted by patent rights may be detrimental to the society. Examine. Could patent pooling be a permanent solution to find vaccines during pandemics?